endo important Flashcards
insulin actions
fasting state- regulates glucose release by the liver
postprandial state- promotes glucose uptake by fat and muscle
hormones which act in opposition to insulin (are counterregulatory)
glucagon, adrenaline, GH and cortisol- they all increase glucose production by the liver and reduce its utilisation in fat and muscle for a given level of insulin
cells which produce insulin
beta cells in the pancreatic islets
cells which produce glucagon
alpha cells
sign of severe insulin resistance
acanthosis nigricans- blackish pigmentation at the nape of the neck and in the axillae
diagnostic criteria for diabetes mellitus
1- random blood glucose measurement >11mmol/L
2- fasting plasma glucose>7mmol/L
3- HbA1c>48mmol/L (6.5%)
4- OGTT: fasting>7mmol/L, 2 hours after glucose >11mmol/L
Type 2 DM management- someone who can tolerate metformin
1 - upon diagnosis, if lifestyle measures still do not get HbA1c <48mmol/L then ofer metformin
2- if HbA1c >58mmol/L then add second drug- sulfonylurea/glitpin/pioglitazone/SGLT-2 inhibitor
3- If HbA1c still rises to or remains above 58mmol/L, then triple therapy should be offered metformin +: - glitpin & sulfonylurea - pioglitazone & sulfonylurea - sulfonylurea & SGLT-2 inhibitor - pioglitazone & SGLT-2 inhibitor OR insulin therapy
Type 2 DM management- someone who cant tolerate metformin
1- upon diagnosis if lifestyle measures do not get HbA1c <48mmol/L, consider a sulfonylurea/glitpin/pioglitazone
2- if the HbA1c rises to above 58mmol/L, then one of the following combinations should be used:
- gliptin + pioglitazone
- gliptin + sulfonylurea
- pioglitazone + sulfonylurea
3- If HbA1c rises to/remains above 58mmol/L then consider insulin therapy
Hypertension management in T2DM
- ACE inhibitors are first line
Same targets as patients without T2DM (140/90 in clinic, 135/85 at home) - Patients with a 10 year cardiovascular risk >10% should be offered a statin (first line atorvastatin)
T1DM management
- target HbA1c<48mmol/L. HbA1c should be monitored every 3-6 months
- blood glucose should be self-monitored at least 4 times a day, including before each meal and before bed
- blood glucose targets 5-7mmol/l on waking and 4-7mmol/l before meals and at other times of day
- treatment of choice= mixed basal-bolus insulin regimen. Twice daily insulin detemir, and offer rapid-acting insulin analogues injjected before meals
- consider adding metformin if BMI>25
hormones produced in the anterior pituitary
- GH
- ACTH
- Prolactin
- thyroid stimulating hormone
- LH
- FSH
treatment hypercalcaemia
- Bisphosphonates- prevent bones releasing calcium
- calcimimetic agents e.g. cinacelcet reduce production of PTH
- calcitonin IV/subcut- given to control very high levels of calcium
- adrenal cortex hormones
- adrenal medulla hormones
- cortex: glucorticoids, mineralcorticoids (aldosterone), sex hormones (androgens)
- medulla: adrenaline (increases heart rate and converts glucose to liver), noradrenaline (vasoconstriction, increases blood pressure)
Phaechromocytoma
symptoms
PHEochromocytoma;
Palpitations
Headache
Episodic sweating
posterior pituitary hormones
vasopressin and oxytocin